Years of investment and research in dementia care have sown seeds of hope. It is expected that by 2050, more than 13 million people over age 65 will be living with Alzheimer's disease and related dementias (ADRD). The National Alzheimer’s Project Act (NAPA) was established in response to the pressing need for innovative solutions in prevention, treatment, and cure. The result was a sevenfold increase in federal funding for ADRD research, which now surpasses $3.7 billion annually. Progress has been made in the genetic understanding of ADRD, prevention strategies, models of dementia care, and the discovery of novel drug therapies. The panelists will discuss recent advances and outline the crucial next steps required to sustain this progress. 

Moderator

Diane Ty

Senior Director, Future of Aging, Milken Institute

Speakers

Elizabeth Fowler

Deputy Administrator and Director of the Center for Medicare and Medicaid Innovation, CMS

Amy Kelley

Deputy Director, National Institute on Aging, National Institutes of Health

Helen Lamont

Director, Disability and Aging Policy Division, Office of the Secretary for Planning and Evaluation, US Department of Health and Human Services

Joanne Pike

President and CEO, Alzheimer's Association